Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 210805
Company: MSN LABORATORIES PRIVATE LTD
Company: MSN LABORATORIES PRIVATE LTD
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
LEVOMILNACIPRAN | LEVOMILNACIPRAN | 20MG | CAPSULE, EXTENDED RELEASE;ORAL | None (Tentative Approval) | None | No | No |
LEVOMILNACIPRAN | LEVOMILNACIPRAN | 40MG | CAPSULE, EXTENDED RELEASE;ORAL | None (Tentative Approval) | None | No | No |
LEVOMILNACIPRAN | LEVOMILNACIPRAN | 80MG | CAPSULE, EXTENDED RELEASE;ORAL | None (Tentative Approval) | None | No | No |
LEVOMILNACIPRAN | LEVOMILNACIPRAN | 120MG | CAPSULE, EXTENDED RELEASE;ORAL | None (Tentative Approval) | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
06/01/2020 | ORIG-1 | Tentative Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/210805Orig1s000TAltr.pdf |